HUP0303961A2 - Gombaellenes szert tartalmazó topikális készítmény - Google Patents
Gombaellenes szert tartalmazó topikális készítményInfo
- Publication number
- HUP0303961A2 HUP0303961A2 HU0303961A HUP0303961A HUP0303961A2 HU P0303961 A2 HUP0303961 A2 HU P0303961A2 HU 0303961 A HU0303961 A HU 0303961A HU P0303961 A HUP0303961 A HU P0303961A HU P0303961 A2 HUP0303961 A2 HU P0303961A2
- Authority
- HU
- Hungary
- Prior art keywords
- composition containing
- topical composition
- antifungal drug
- topically
- group
- Prior art date
Links
- 239000003429 antifungal agent Substances 0.000 title abstract 2
- 230000000699 topical effect Effects 0.000 title abstract 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 230000000629 anti-dermatophyte Effects 0.000 abstract 1
- 230000001857 anti-mycotic effect Effects 0.000 abstract 1
- 229940121375 antifungal agent Drugs 0.000 abstract 1
- 239000002543 antimycotic Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229960001259 diclofenac Drugs 0.000 abstract 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229960000905 indomethacin Drugs 0.000 abstract 1
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical class C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 abstract 1
- 229960002722 terbinafine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A találmány antimikotikus, pontosabban anti-dermatofita aktivitásútopikális készítményre vonatkozik, mely tartalmaz egy következőkbőlálló csoportból kiválasztott gombaellenes szert: terbinafin éstopikálisan elfogadható sói, és egy következőkből álló csoportbólkiválasztott második szert: diklofenak; indometacin, és az említettkét vegyület topikálisan elfogadható sói, és legalább egy topikálisanelfogadható hordozót. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0108082.9A GB0108082D0 (en) | 2001-03-30 | 2001-03-30 | Topical composition |
PCT/EP2002/003547 WO2002078648A2 (en) | 2001-03-30 | 2002-03-28 | Topical composition comprising an antifungal |
Publications (1)
Publication Number | Publication Date |
---|---|
HUP0303961A2 true HUP0303961A2 (hu) | 2004-03-29 |
Family
ID=9911965
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0303961A HUP0303961A2 (hu) | 2001-03-30 | 2002-03-28 | Gombaellenes szert tartalmazó topikális készítmény |
Country Status (20)
Country | Link |
---|---|
US (1) | US20040101538A1 (hu) |
EP (1) | EP1390031B1 (hu) |
JP (1) | JP2004528317A (hu) |
CN (1) | CN100366244C (hu) |
AR (1) | AR033023A1 (hu) |
AT (1) | ATE288752T1 (hu) |
AU (1) | AU2002246119B2 (hu) |
CA (1) | CA2437789A1 (hu) |
CZ (1) | CZ295223B6 (hu) |
DE (1) | DE60202946T2 (hu) |
ES (1) | ES2236495T3 (hu) |
GB (1) | GB0108082D0 (hu) |
HK (1) | HK1063282A1 (hu) |
HU (1) | HUP0303961A2 (hu) |
IL (1) | IL157334A0 (hu) |
NZ (1) | NZ528407A (hu) |
PL (1) | PL362858A1 (hu) |
PT (1) | PT1390031E (hu) |
WO (1) | WO2002078648A2 (hu) |
ZA (1) | ZA200306434B (hu) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR041021A1 (es) | 2002-08-22 | 2005-04-27 | Novartis Consumer Health Sa | Composicion topica |
US8404751B2 (en) * | 2002-09-27 | 2013-03-26 | Hallux, Inc. | Subunguicide, and method for treating onychomycosis |
US20060165803A1 (en) * | 2002-12-18 | 2006-07-27 | Celia Palacin | Pharmaceutical compositions of sertaconazole for vaginal use |
US20040126343A1 (en) * | 2002-12-26 | 2004-07-01 | Garshowitz Solomon David | Nail drug delivery |
CA2538991A1 (en) | 2003-09-18 | 2005-03-31 | Children's Medical Center Corporation | Treatment of severe distal colitis |
US20050137262A1 (en) * | 2003-12-22 | 2005-06-23 | Hu Patrick C. | Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses |
US20050238672A1 (en) * | 2004-04-27 | 2005-10-27 | Nimni Marcel E | Antifungal drug delivery |
US7740875B2 (en) * | 2004-10-08 | 2010-06-22 | Mediquest Therapeutics, Inc. | Organo-gel formulations for therapeutic applications |
US20060078580A1 (en) * | 2004-10-08 | 2006-04-13 | Mediquest Therapeutics, Inc. | Organo-gel formulations for therapeutic applications |
US20060142304A1 (en) * | 2004-12-27 | 2006-06-29 | Michael Southall | Method for treating or preventing pruritic and neurogenic skin disorders |
US20060251593A1 (en) * | 2005-04-07 | 2006-11-09 | Work By Docs, Inc. | Colored nail enamel treatment |
FR2892023B1 (fr) * | 2005-10-14 | 2009-09-25 | Galderma Sa | Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale |
CN100364520C (zh) * | 2006-04-24 | 2008-01-30 | 魏锐 | 盐酸特比萘芬栓剂及其制备方法 |
PT2018164T (pt) | 2006-05-12 | 2017-06-12 | Christian Noe | Utilização de preparações combinadas que compreendem antimicóticos |
US20080317684A1 (en) * | 2006-09-06 | 2008-12-25 | Isw Group, Inc. | Topical Compositions |
EP2055298A1 (en) | 2007-10-30 | 2009-05-06 | Novartis AG | Topical composition |
ES2316312B1 (es) * | 2008-06-20 | 2010-02-08 | Ignacio Umbert Millet | Composicion farmaceutica dermatologica para el tratamiento de patologias de inflamacion de la piel, tales como por ejemplo dermatitis, dermatitis atopica, vitiligo, alopecia areata, acne, psoriasis y prurito,y combinaciones de las mismas. |
CA2731455A1 (en) | 2008-07-23 | 2010-01-28 | Gregor Cevc | Methods of administering topical antifungal formulations for the treatment of fungal infections |
EP2416759A2 (en) * | 2009-04-08 | 2012-02-15 | Cadila Healthcare Limited | Stable pharmaceutical compositions of diclofenac |
DE102009038512A1 (de) | 2009-07-30 | 2011-02-10 | Technische Universität Braunschweig | Arzneimittelformulierung zur Behandlung von Nagelerkrankungen |
CN102423293B (zh) * | 2011-01-28 | 2013-05-29 | 舒泰神(北京)生物制药股份有限公司 | 一种硝酸奥昔康唑的微乳凝胶制剂 |
WO2012126899A2 (en) * | 2011-03-18 | 2012-09-27 | Katholieke Universiteit Leuven Ku Leuven Research & Development | Inhibition and treatment of biofilms |
JP6339940B2 (ja) * | 2011-12-20 | 2018-06-06 | ビョーメ バイオサイエンシズ ピーブイティー.リミテッド | 真菌感染症の治療用の局所用オイル組成物 |
JP6189962B2 (ja) | 2012-10-09 | 2017-08-30 | ザ プロクター アンド ギャンブル カンパニー | 相乗作用する美容成分の組み合わせを特定する方法 |
WO2014059008A1 (en) | 2012-10-09 | 2014-04-17 | The Procter & Gamble Company | Method of identifying or evaluating beneficial actives and compositions containing the same |
US9433680B2 (en) | 2013-01-31 | 2016-09-06 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
US8778365B1 (en) | 2013-01-31 | 2014-07-15 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
US9452173B2 (en) | 2013-01-31 | 2016-09-27 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
US9446131B2 (en) | 2013-01-31 | 2016-09-20 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
US9144538B2 (en) | 2013-02-08 | 2015-09-29 | The Procter & Gamble Company | Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin |
US9138393B2 (en) | 2013-02-08 | 2015-09-22 | The Procter & Gamble Company | Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin |
CA2904703A1 (en) | 2013-03-14 | 2014-10-02 | Hallux, Inc. | Method of treating infections, diseases or disorders of nail unit |
WO2014167554A2 (en) * | 2013-04-12 | 2014-10-16 | Vyome Biosciences Pvt. Ltd. | Composition and formulation of antimicrobial agents, processes thereof and methods for treating microbial infections |
RU2702898C2 (ru) | 2014-09-10 | 2019-10-14 | Гск Консьюмер Хелткер С.А. | Композиции диклофенака натрия для местного применения |
CN105193726B (zh) * | 2015-11-08 | 2018-01-26 | 长沙佰顺生物科技有限公司 | 一种治疗灰指甲的药物组合物 |
WO2017091168A1 (en) | 2015-11-28 | 2017-06-01 | Pharmacti̇ve İlaç San. Ve Ti̇c. A.Ş. | A topical spray comprising isoconazole nitrate and difluocortolone valerate |
ES2562985B1 (es) * | 2015-12-31 | 2016-09-14 | Enrique Blanxart Sena | Composición farmacéutica para el tratamiento de lesiones de la piel |
WO2017216722A2 (en) * | 2016-06-13 | 2017-12-21 | Vyome Biosciences Pvt. Ltd. | Synergistic antifungal compositions and methods thereof |
EP3468544A2 (en) * | 2016-06-13 | 2019-04-17 | Vyome Therapeutics Limited | Synergistic antifungal compositions and methods thereof |
EP3482744A1 (de) * | 2017-11-14 | 2019-05-15 | ProFem GmbH | Emulsionen zur topischen behandlung urogenitaler und dermaler infektionen |
EP3482743A1 (de) * | 2017-11-14 | 2019-05-15 | ProFem GmbH | Emulsionen zur behandlung von scheideninfektionen |
MX2020005056A (es) | 2017-11-14 | 2020-10-28 | Profem Gmbh | Emulsiones para el tratamiento tópico de infecciones dérmicas y de mucosas. |
CN111432802A (zh) | 2017-12-04 | 2020-07-17 | 强生消费者公司 | 含有非甾体抗炎药的局部用乳液组合物 |
EP3760231A4 (en) * | 2018-02-27 | 2022-01-19 | Hisamitsu Pharmaceutical Co., Inc. | EMULSIFIED GEL COMPOSITION |
US20210077393A1 (en) * | 2018-02-27 | 2021-03-18 | Hisamitsu Pharmaceutical Co., Inc. | Diclofenac-containing emulsified gel composition |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH655656B (hu) * | 1982-10-07 | 1986-05-15 | ||
IT1247529B (it) * | 1991-04-24 | 1994-12-17 | Poli Ind Chimica Spa | Composizioni farmaceutiche in forma di schiuma per somministrazione intravaginale, cutanea e orale |
HU223343B1 (hu) * | 1991-05-20 | 2004-06-28 | Novartis Ag. | Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására |
FR2722102B1 (fr) * | 1994-07-11 | 1996-08-23 | Cird Galderma | Utilisation de particules creuses deformables dans une composition cosmetique et/ou dermatologique, contenant des matieres grasses |
US6159977A (en) * | 1998-11-16 | 2000-12-12 | Astan, Inc. | Therapeutic anti-fungal nail preparation |
-
2001
- 2001-03-30 GB GBGB0108082.9A patent/GB0108082D0/en not_active Ceased
-
2002
- 2002-03-27 AR ARP020101137A patent/AR033023A1/es unknown
- 2002-03-28 PT PT02714197T patent/PT1390031E/pt unknown
- 2002-03-28 WO PCT/EP2002/003547 patent/WO2002078648A2/en active IP Right Grant
- 2002-03-28 DE DE60202946T patent/DE60202946T2/de not_active Expired - Fee Related
- 2002-03-28 ES ES02714197T patent/ES2236495T3/es not_active Expired - Lifetime
- 2002-03-28 CZ CZ20032599A patent/CZ295223B6/cs not_active IP Right Cessation
- 2002-03-28 IL IL15733402A patent/IL157334A0/xx unknown
- 2002-03-28 HU HU0303961A patent/HUP0303961A2/hu unknown
- 2002-03-28 CA CA002437789A patent/CA2437789A1/en not_active Abandoned
- 2002-03-28 JP JP2002576915A patent/JP2004528317A/ja active Pending
- 2002-03-28 PL PL02362858A patent/PL362858A1/xx unknown
- 2002-03-28 CN CNB028076079A patent/CN100366244C/zh not_active Expired - Fee Related
- 2002-03-28 AU AU2002246119A patent/AU2002246119B2/en not_active Ceased
- 2002-03-28 EP EP02714197A patent/EP1390031B1/en not_active Expired - Lifetime
- 2002-03-28 AT AT02714197T patent/ATE288752T1/de not_active IP Right Cessation
- 2002-03-28 NZ NZ528407A patent/NZ528407A/en unknown
- 2002-03-28 US US10/472,697 patent/US20040101538A1/en not_active Abandoned
-
2003
- 2003-08-19 ZA ZA200306434A patent/ZA200306434B/en unknown
-
2004
- 2004-07-15 HK HK04105221A patent/HK1063282A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
PT1390031E (pt) | 2005-05-31 |
CZ295223B6 (cs) | 2005-06-15 |
JP2004528317A (ja) | 2004-09-16 |
ZA200306434B (en) | 2004-04-29 |
WO2002078648A2 (en) | 2002-10-10 |
EP1390031A2 (en) | 2004-02-25 |
EP1390031B1 (en) | 2005-02-09 |
NZ528407A (en) | 2006-04-28 |
DE60202946D1 (de) | 2005-03-17 |
PL362858A1 (en) | 2004-11-02 |
AR033023A1 (es) | 2003-12-03 |
ATE288752T1 (de) | 2005-02-15 |
US20040101538A1 (en) | 2004-05-27 |
IL157334A0 (en) | 2004-02-19 |
WO2002078648A3 (en) | 2003-12-11 |
CA2437789A1 (en) | 2002-10-10 |
ES2236495T3 (es) | 2005-07-16 |
CN100366244C (zh) | 2008-02-06 |
GB0108082D0 (en) | 2001-05-23 |
CN1531430A (zh) | 2004-09-22 |
AU2002246119B2 (en) | 2005-04-07 |
CZ20032599A3 (cs) | 2004-09-15 |
HK1063282A1 (en) | 2004-12-24 |
DE60202946T2 (de) | 2005-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0303961A2 (hu) | Gombaellenes szert tartalmazó topikális készítmény | |
RS52169B (en) | STABLE LAKVINIMOD PREPARATIONS | |
SE0302811D0 (sv) | Novel compounds | |
BRPI0417717A (pt) | composto, composição farmacêutica, e, uso de um composto | |
EA200501586A1 (ru) | Фармацевтические продукты | |
MY132882A (en) | Use of cyp2d6 inhibitors in combination therapies | |
RS53895B1 (en) | ATP-BINDING CASSETTE TRANSPORT MODULATORS | |
NO20043367L (no) | Oralt farmasoytisk preparat | |
ATE509636T1 (de) | Kombination aus einem cholinesterase-hemmer und einer verbindung mit 5-ht6-rezeptor-affinität | |
ATE365740T1 (de) | Substituierte pyrazolopyrimidine | |
EA200701790A1 (ru) | Твёрдый фармацевтический дозированный состав | |
DK1337518T3 (da) | Piperazinylpyrazinforbindelser som antagonister for serotonin-5-HT2-receptoren | |
NO20034627L (no) | Oralt avleverbart farmasöytisk preparat innbefattende en aktiv forbindelsemed en aminosulfonylgruppe (cox-2 inhibitor) en polyetylenglykolog et friradikal-fjernende antioksidasjonsmiddel | |
PT1506185E (pt) | Compostos novos e sua utilizacao | |
ATE441630T1 (de) | Substituierte cyclopenten-verbindungen | |
MA30042B1 (fr) | Composes calcilytiques | |
DE60332656D1 (de) | Topische stabilisierte dosierungsformen für prostaglandin e-verbindungen | |
NO20064808L (no) | Orale matrixformuleringer med licarbazepin | |
BR0212353A (pt) | Composto, composição farmacêutica, e, uso de um composto | |
ATE321538T1 (de) | Orale darreichungsform für pyridin-2- ylmethylsulfinyl-1h-benzimidazole | |
RS51534B (en) | NEW COMPOUND OF SINUSOID IF CURRENT INHIBITORS AND CALCIUM INHIBITOR AND PHARMACEUTICAL MIXTURE CONTAINED BY IT | |
DK1494650T3 (da) | Farmaceutisk formulering, der indeholder melatonin | |
SE0403086D0 (sv) | Compounds | |
BRPI0520821A2 (pt) | formulações farmacêuticas de fenofibrato com biodisponibilidade melhorada | |
MXPA02010828A (es) | Composicion farmaceutica en capsulas que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |